286 related articles for article (PubMed ID: 30995568)
1. Comparative analysis of pyrimidine substituted aminoacyl-sulfamoyl nucleosides as potential inhibitors targeting class I aminoacyl-tRNA synthetases.
Nautiyal M; De Graef S; Pang L; Gadakh B; Strelkov SV; Weeks SD; Van Aerschot A
Eur J Med Chem; 2019 Jul; 173():154-166. PubMed ID: 30995568
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Evaluation of 1,3-Dideazapurine-Like 7-Amino-5-Hydroxymethyl-Benzimidazole Ribonucleoside Analogues as Aminoacyl-tRNA Synthetase Inhibitors.
Zhang B; Pang L; Nautiyal M; De Graef S; Gadakh B; Lescrinier E; Rozenski J; Strelkov SV; Weeks SD; Van Aerschot A
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081246
[TBL] [Abstract][Full Text] [Related]
3. Family-wide analysis of aminoacyl-sulfamoyl-3-deazaadenosine analogues as inhibitors of aminoacyl-tRNA synthetases.
Zhang B; De Graef S; Nautiyal M; Pang L; Gadakh B; Froeyen M; Van Mellaert L; Strelkov SV; Weeks SD; Van Aerschot A
Eur J Med Chem; 2018 Mar; 148():384-396. PubMed ID: 29477072
[TBL] [Abstract][Full Text] [Related]
4. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review.
Bouz G; Zitko J
Bioorg Chem; 2021 May; 110():104806. PubMed ID: 33799176
[TBL] [Abstract][Full Text] [Related]
6. 5'-(N-aminoacyl)-sulfonamido-5'-deoxyadenosine: attempts for a stable alternative for aminoacyl-sulfamoyl adenosines as aaRS inhibitors.
Gadakh B; Smaers S; Rozenski J; Froeyen M; Van Aerschot A
Eur J Med Chem; 2015 Mar; 93():227-36. PubMed ID: 25686591
[TBL] [Abstract][Full Text] [Related]
7. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
Lv PC; Zhu HL
Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
[TBL] [Abstract][Full Text] [Related]
8. Structural Insights into the Binding of Natural Pyrimidine-Based Inhibitors of Class II Aminoacyl-tRNA Synthetases.
Pang L; Nautiyal M; De Graef S; Gadakh B; Zorzini V; Economou A; Strelkov SV; Van Aerschot A; Weeks SD
ACS Chem Biol; 2020 Feb; 15(2):407-415. PubMed ID: 31869198
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity studies of novel anhydrohexitol-based Leucyl-tRNA synthetase inhibitors.
De Ruysscher D; Pang L; Lenders SMG; Cappoen D; Cos P; Rozenski J; Strelkov SV; Weeks SD; Van Aerschot A
Eur J Med Chem; 2021 Feb; 211():113021. PubMed ID: 33248851
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of beta-ketophosphonate analogs of glutamyl and glutaminyl adenylate, and selective inhibition of the corresponding bacterial aminoacyl-tRNA synthetases.
Balg C; Blais SP; Bernier S; Huot JL; Couture M; Lapointe J; Chênevert R
Bioorg Med Chem; 2007 Jan; 15(1):295-304. PubMed ID: 17049867
[TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of affinity modification of several aminoacyl-tRNA synthetases with gamma-(p-azidoanilide)-ATP].
Bulychev NA; Lavrik OI; Nevinskiĭ GA
Mol Biol (Mosk); 1980; 14(3):558-67. PubMed ID: 6995829
[TBL] [Abstract][Full Text] [Related]
12. Aminoalkyl adenylate and aminoacyl sulfamate intermediate analogues differing greatly in affinity for their cognate Staphylococcus aureus aminoacyl tRNA synthetases.
Forrest AK; Jarvest RL; Mensah LM; O'Hanlon PJ; Pope AJ; Sheppard RJ
Bioorg Med Chem Lett; 2000 Aug; 10(16):1871-4. PubMed ID: 10969988
[TBL] [Abstract][Full Text] [Related]
13. Role of aminoacyl-tRNA synthetases in infectious diseases and targets for therapeutic development.
Dewan V; Reader J; Forsyth KM
Top Curr Chem; 2014; 344():293-329. PubMed ID: 23666077
[TBL] [Abstract][Full Text] [Related]
14. N-alkylated aminoacyl sulfamoyladenosines as potential inhibitors of aminoacylation reactions and microcin C analogues containing D-amino acids.
Vondenhoff GH; Pugach K; Gadakh B; Carlier L; Rozenski J; Froeyen M; Severinov K; Van Aerschot A
PLoS One; 2013; 8(11):e79234. PubMed ID: 24223911
[TBL] [Abstract][Full Text] [Related]
15. Acylated sulfonamide adenosines as potent inhibitors of the adenylate-forming enzyme superfamily.
De Ruysscher D; Pang L; De Graef S; Nautiyal M; De Borggraeve WM; Rozenski J; Strelkov SV; Weeks SD; Van Aerschot A
Eur J Med Chem; 2019 Jul; 174():252-264. PubMed ID: 31048140
[TBL] [Abstract][Full Text] [Related]
16. Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery.
Pang L; Weeks SD; Van Aerschot A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578647
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and aminoacyl-tRNA synthetase inhibitory activity of aspartyl adenylate analogs.
Bernier S; Akochy PM; Lapointe J; Chênevert R
Bioorg Med Chem; 2005 Jan; 13(1):69-75. PubMed ID: 15582453
[TBL] [Abstract][Full Text] [Related]
18. Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present.
Gadakh B; Van Aerschot A
Expert Opin Ther Pat; 2012 Dec; 22(12):1453-65. PubMed ID: 23062029
[TBL] [Abstract][Full Text] [Related]
19. Base substituted 5'-O-(N-isoleucyl)sulfamoyl nucleoside analogues as potential antibacterial agents.
Gadakh B; Vondenhoff G; Lescrinier E; Rozenski J; Froeyen M; Van Aerschot A
Bioorg Med Chem; 2014 May; 22(10):2875-86. PubMed ID: 24746466
[TBL] [Abstract][Full Text] [Related]
20. Aminoacyl-tRNA synthetase inhibitors as potential antibiotics.
Vondenhoff GH; Van Aerschot A
Eur J Med Chem; 2011 Nov; 46(11):5227-36. PubMed ID: 21968372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
